Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry
Systemic therapies can substantially improve survival in patients with NSCLC with LM at diagnosis and should therefore no longer be considered an automatic exclusion criterion for active treatment.
Authors
- Lizza Hendriks (ORCID: https://orcid.org/0000-0002-3521-2535)
- Dieta Brandsma (ORCID: https://orcid.org/0000-0001-7998-9904)
- Juliette Degens (ORCID: https://orcid.org/0000-0003-0279-9656)
- Francesca Rita Ogliari (ORCID: https://orcid.org/0000-0003-1594-2407)
- Martinus P G Broen (ORCID: https://orcid.org/0000-0002-8834-2202)
- Mandy Jongbloed (ORCID: https://orcid.org/0000-0003-4686-9169)
- Ronald Damhuis (ORCID: https://orcid.org/0000-0001-7248-7047)
- Jarno W J Huijs (ORCID: https://orcid.org/0000-0001-9117-6885)
- Dirk K.M. De Ruysscher
- Monique H.M.E. Anten
Institutions
- Vita-Salute San Raffaele University (IT)
- Maastricht University Medical Centre (NL)
- The Netherlands Cancer Institute (NL)
- Maastricht University (NL)
- IRCCS Ospedale San Raffaele (IT)
- Zuyderland Medisch Centrum (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108806
- Citations
- 3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56